Back to search
FDAFDA · Food and drugs·Recall number Z-2936-2026

BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid test, in vitro diagnostic

Published August 19, 2026 · Recall initiated: June 24, 2026

Summary

FDA records medical device Class II recall Z-2936-2026, published August 19, 2026 and initiated June 24, 2026. Recalling firm: BioFire Diagnostics, LLC; Status: Ongoing; Reported quantity: 2,370 pouches (79 kits); Lot: Part Number: 423742 UDI-DI code: 00815381020529 Pouch Lot: 3VLB25 Kit Lot: 1872125. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to increase in false negative results

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BioFire Diagnostics, LLC
Distributor
U.S. Nationwide distribution in the states of AL, AR, IA, IL, KS, LA, MN, MO, TX, and WI.
Lot
Part Number: 423742 UDI-DI code: 00815381020529 Pouch Lot: 3VLB25 Kit Lot: 1872125
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid test, in vitro diagnostic recalled?

Yes. FDA published recall Z-2936-2026 on August 19, 2026. Reported hazard: Due to increase in false negative results

What should I do if I have this product?

Voluntary: Firm initiated